Data as of Mar 10
| +0.08 / +4.49%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The median estimate represents a +1,190.32% increase from the last price of 1.86.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.